Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41.

[1]  A. Debnath,et al.  N-Substituted Pyrrole Derivatives as Novel Human Immunodeficiency Virus Type 1 Entry Inhibitors That Interfere with the gp41 Six-Helix Bundle Formation and Block Virus Fusion , 2004, Antimicrobial Agents and Chemotherapy.

[2]  A. Debnath,et al.  A novel assay to identify entry inhibitors that block binding of HIV-1 gp120 to CCR5. , 2004, Virology.

[3]  Erik De Clercq,et al.  Antiviral drugs in current clinical use. , 2004 .

[4]  Shibo Jiang,et al.  High throughput screening and characterization of HIV-1 entry inhibitors targeting gp41: theories and techniques. , 2004, Current pharmaceutical design.

[5]  Shibo Jiang,et al.  Tannin inhibits HIV-1 entry by targeting gp41. , 2004, Acta pharmacologica Sinica.

[6]  E. De Clercq,et al.  Development of a cell-based enzyme-linked immunosorbent assay for high-throughput screening of HIV type 1 entry inhibitors targeting the coreceptor CXCR4. , 2003, AIDS research and human retroviruses.

[7]  H. Nagawa,et al.  Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding. , 2003, The Journal of allergy and clinical immunology.

[8]  Chung S. Yang,et al.  Mechanisms of cancer prevention by tea constituents. , 2003, The Journal of nutrition.

[9]  Yuxian He,et al.  Analysis of the immunogenic properties of a single-chain polypeptide analogue of the HIV-1 gp120-CD4 complex in transgenic mice that produce human immunoglobulins. , 2003, Vaccine.

[10]  R. Doms,et al.  The entry of entry inhibitors: A fusion of science and medicine , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Shibo Jiang,et al.  Determination of the HIV-1 gp41 fusogenic core conformation modeled by synthetic peptides: applicable for identification of HIV-1 fusion inhibitors , 2003, Peptides.

[12]  Anthony S Fauci,et al.  HIV and AIDS: 20 years of science , 2003, Nature Medicine.

[13]  B. Frei,et al.  Tea Catechins and Polyphenols: Health Effects, Metabolism, and Antioxidant Functions , 2003, Critical reviews in food science and nutrition.

[14]  Y. Yu,et al.  HIV gp41 binding phenolic components from Fraxinus sieboldiana var. angustata. , 2002, Planta medica.

[15]  Shibo Jiang,et al.  Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibotte. , 2002, Life sciences.

[16]  D. Noonan,et al.  Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. , 2002, AIDS.

[17]  A. Debnath,et al.  Peptide and non-peptide HIV fusion inhibitors. , 2002, Current pharmaceutical design.

[18]  H. Ikigai,et al.  Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). , 2002, Antiviral research.

[19]  L. Leung,et al.  Theaflavins in black tea and catechins in green tea are equally effective antioxidants. , 2001, The Journal of nutrition.

[20]  E. Farnworth,et al.  A review of latest research findings on the health promotion properties of tea. , 2001, The Journal of nutritional biochemistry.

[21]  C. S. Yang,et al.  Effects of tea consumption on nutrition and health. , 2000, The Journal of nutrition.

[22]  Y. Morikawa,et al.  Biochemical characterization of casein kinase II as a protein kinase responsible for stimulation of HIV-1 protease in vitro. , 2000, Biochemical and biophysical research communications.

[23]  H. Mukhtar,et al.  Tea polyphenols: prevention of cancer and optimizing health. , 2000, The American journal of clinical nutrition.

[24]  A. K. Debnath,et al.  A salt bridge between an N-terminal coiled coil of gp41 and an antiviral agent targeted to the gp41 core is important for anti-HIV-1 activity. , 2000, Biochemical and biophysical research communications.

[25]  Shibo Jiang,et al.  Convenient cell fusion assay for rapid screening for HIV entry inhibitors , 2000, Photonics West - Biomedical Optics.

[26]  A. Debnath,et al.  A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody. , 1999, Journal of virological methods.

[27]  O. Nishimura,et al.  A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Min Lu,et al.  A Conformation-Specific Monoclonal Antibody Reacting with Fusion-Active gp41 from the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein , 1998, Journal of Virology.

[29]  E. Clercq,et al.  Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4 , 1997, The Journal of experimental medicine.

[30]  E. De Clercq,et al.  Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4. , 1997, Antiviral research.

[31]  M. Mccarty,et al.  natural antimutagenic agents may prolong efficacy of human immunodeficiency virus drug therapy. , 1997, Medical hypotheses.

[32]  J. Hoxie,et al.  Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent , 1997, Journal of virology.

[33]  S. Ōmura,et al.  Chloropeptins, new anti-HIV antibiotics inhibiting gp120-CD4 binding from Streptomyces sp. II. Structure elucidation of chloropeptin I. , 1997, The Journal of antibiotics.

[34]  Stephen C. Blacklow,et al.  A trimeric structural domain of the HIV-1 transmembrane glycoprotein , 1995, Nature Structural Biology.

[35]  I Tomita,et al.  Antioxidative effects of black tea theaflavins and thearubigin on lipid peroxidation of rat liver homogenates induced by tert-butyl hydroperoxide. , 1994, Biological & pharmaceutical bulletin.

[36]  Shibo Jiang,et al.  HIV-1 inhibition by a peptide , 1993, Nature.

[37]  G. Gilljam.  Envelope glycoproteins of HIV-1, HIV-2, and SIV purified with Galanthus nivalis agglutinin induce strong immune responses. , 1993, AIDS research and human retroviruses.

[38]  H. Ikigai,et al.  Bactericidal catechins damage the lipid bilayer. , 1993, Biochimica et biophysica acta.

[39]  T. Mizuno,et al.  Inhibitory effect of tannic acid sulfate and related sulfates on infectivity, cytopathic effect, and giant cell formation of human immunodeficiency virus. , 1992, Planta medica.

[40]  H. Sakagami,et al.  Inhibition of human immunodeficiency viral replication by tannins and related compounds. , 1992, Antiviral research.

[41]  Shibo Jiang,et al.  Rapid Prescreening for Antiviral Agents against HIV-1 Based on Their Inhibitory Activity in Site-Directed Immunoassays. II. Porphyrins Reacting with the V3 Loop of gp120 , 1992 .

[42]  P. Tao.  [The inhibitory effects of catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and DNA polymerases]. , 1991, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.

[43]  S. Jiang,et al.  Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41 [published erratum appears in J Exp Med 1992 Feb 1;175(2):621] , 1991, The Journal of experimental medicine.

[44]  H. Ushijima,et al.  Inhibition of rotavirus and enterovirus infections by tea extracts. , 1991, Japanese journal of medical science & biology.

[45]  T. Chou,et al.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.